Site Map
Japanese
TAISHO PHARMACEUTICAL HOLDINGS
Corporate Profile
A Message from Management
Corporate Data
Board of Directors
Philosophy and Declaration of Corporate Conduct
History
Facilities
Group Companies
Our Business
Self-Medication
Prescription Pharmaceutical
Overseas Development
Social and Environment Activities
Compliance
Environmental Measures
Support for Research in Life Sciences
Information Disclosure
Simulation of Interest in Self-Medication
Contribution to Cultural Activities
News Releases
News Releases
Oct 1, 2019
Taisho and Moberg Pharma sign exclusive license agreement for the development and commercialization of MOB-015 in Japan
Jul 2, 2019
Taisho Completed Procedures for the Acquisition of UPSA SAS(Taisho Pharmaceutical Holdings)
Feb 28, 2019
Notice Regarding the Tender Offer for Shares of Duoc Hau Giang Pharmaceutical JSC(Taisho Pharmaceutical Holdings)
Dec 19, 2018
Taisho Agreed To Acquire UPSA SAS, A French Pharmaceutical Manufacturer, and its Business Assets, Owned by Bristol-Myers Squibb Company(Taisho Pharmaceutical Holdings)
more
Page Top